# Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

> **NCT00198471** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 10 (—)

## Conditions studied

- Vitreous Detachment
- Diabetic Retinopathy

## Interventions

- **DRUG:** Vitrase

## Key facts

- **NCT ID:** NCT00198471
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 10 (—)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198471, "Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00198471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*